when is tirzepatide approved FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide Cuts Risk of Diabetes
Description
[75] An observational study on patients with obesity and type 2 diabetes and heart failure with preserved ejection fraction reported that tirzepatide had a lower risk of hospitalization for heart failure and all-cause death combined than sitagliptin
Drugs.com
The generic medications are expected to be less expensive than Mounjaro and Zepbound
Riley RD, Higgins JPT, Deeks JJ (2011) Interpretation of random effects meta-analyses
